In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C] methylpiperdin-4-yl propionate ([11C]PMP)

Synapse

Volumn 22, Issue 2, 1996, Pages 123-131

  Kilbourn, Michael R ^a   Snyder, Scott E ^a   Sherman, Phillip S ^a   Kuhl, David E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Carbon 11; Emission computed tomography; Mouse; Primate

Indexed keywords

1 METHYL 4 PIPERIDYL ACETATE C 11; 1 METHYL 4 PIPERIDYL PROPIONATE C 11; ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; DYFLOS; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; CEREBELLUM; CHROMATOGRAPHY; CONTROLLED STUDY; CORPUS STRIATUM; DRUG PENETRATION; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME SUBSTRATE; FEMALE; HIPPOCAMPUS; HYDROLYSIS; INTRAVENOUS DRUG ADMINISTRATION; MONKEY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; TISSUE DISTRIBUTION;

ACETATES; ACETYLCHOLINESTERASE; ANIMALS; BRAIN; FEMALE; MACACA NEMESTRINA; MICE; MICE, INBRED STRAINS; PROPIONATES; RADIOLIGAND ASSAY; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030061557     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199602)22:2<123::AID-SYN5>3.0.CO;2-F     Document Type: Article

References (38)

1. 11C)deprenyl. J. Neurochem., 49:522-527.
2. Bierer, L.M., Haroutunian, V., Gabriel, S , Knott, P.J., Carlin, L.S., Purohit, D.P., Perl, O.P., Schmeidler, J., Kanof, P., and Davis, K.L. (1995) Neurochemical correlates of dementia severity in Alzheimer's disease: Relative importance of the cholinergic defecits. J. Neurochem., 64:740-760.
3. Chen, Y.L., Nielsen, J., Hedberg, K., Dunaiskis, A . Jones, S., Russo, L., Johnson, J., Ives, J., and Liston, D (1992) Syntheses, resolution and structure-activity relationships of potent acetylcholinesterase inhibitors. 8-carbaphysostigmine analogues. J. Med. Chem., 35: 1429-1434.
4. 11C-methyl]-benztropine. Synapse, 5:213-223.
5. Durkin, T., Ayad, G., Ebel, A., and Mandel, P. (1977) Regional acetylcholine turnover rates in the brains of three inbred strains of mice: Correlations with some inter-strain behavioural differences Brain Res., 136:475-486.
6. Eckelman, W.C., Reba, R.C., Rzeszotarski, W.J., Gibson, R.E., Hill, T., Holman, B.L., Budinger, T.F., Conklin, J.J., Eng, R., and Grissom, M.P. (1984) External imaging of cerebral muscarinic acetylcholine receptors. Science, 223:291-293.
7. Frey, K.A., Ciliax, B., and Agranoff, B.W. (1991) Quantitative in vivo receptor binding IV. Detection of muscarinic receptor down-regulation by equilibrium and by tracer kinetic methods. Neurochem. Res., 16:1017-1023.
8. 13C]scopolamine and positron emission tomography. J. Cereb. Blood Flow Metab., 12:147-154.
9. Glowinski, J., and Iversen, L.L. (1966) Regional studies of cetecholamines in the rat brain-1. J. Neurochem., 13:655-676.
10. Gordon, M.N., and Finch, C.E. (1984) Topochemical localization of choline acetyltransferase and acetylcholinesterase in mouse brain. Brain Res., 308:364-368.
11. Hammond, P., and Brimijoin, S. (1988) Acetylcholinesterase in Huntington's and Alzheimer's disease: Simultaneous enzyme assay and immunoassay of multiple brain regions. J. Neurochem., 50: 1111-1116.
12. Hammond, P., Rao, R., Koenigsberger, C., and Brimijoin, S. (1994) Regional variation in expression of acetylcholinesterase mRNA in adult rat brain analyzed by in situ hybridization. Proc. Natl. Acad. Sci. USA, 91:10933-10937
13. Hucho, F., Jarv, J., and Wiese, C. (1991) Substrate-binding sites in acetylcholinesterase. Trends Pharmacol. Sci., 12:422-426.
14. Irie, T., Fukushi, K., Akimoto, Y., Tamagami, H., and Nozaki, T. (1994) Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AChE) in vivo. Nucl. Med. Biol , 21.801-808.
15. Johnson, C.D., and Russell, R.L. (1975) A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem., 64:229-238.
16. Jung, Y.-W., Van Dort, M.E., Gildersleeve, D.L., and Wieland, D.M. (1990) A radiotracer for mapping cholinergic neurons of the brain. J. Med. Chem., 33:2065-2068.
17. Kilbourn, M.R., Jung, Y.-W., Haka, M.S., Gildersleeve, D.L., Kuhl, D.E., and Wieland, D.M. (1990) Mouse brain distribution of a carbon-11 labeled vesamicol derivative: Presynaptic marker of cholinergic neurons. Life. Sci., 47:1955-1963.
18. 11C]Tropanyl benzilate-binding to muscarinic eholinergic receptors: Methodology and kinetic modeling alternatives. J. Cereb. Blood Flow Metab., 14:85-99.
19. Kuhl, D.E., Koeppe, R.A., Fessier, J.A., Minoshima, S., Ackermann, R.J., Carey, J.E., Gildersleeve, D.L., Frey, K.A., and Wieland, D.M. (1994) In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J. Nucl. Med., 35:405-410.
20. Landwehrmeyer, B., Probst, A., Palacios, J.M., and Mengod, G. (1993) Expression of acetylcholinesterase messenger RNA in human brain. An in situ hybridization study. Neuroscience, 57:615-634.
21. Mesulam, M.M., Mufson, E.J., Levey, A.I., and Wainer, B H. (1984) Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry. Neuroscience, 12:669-686.
22. 120I]-4-iodolevetimide. J. Cereb. Blood Flow Metab., 12:562-570.
23. 123-iododexetimide and single-photon emission computed tomography in epilepsy. Ann. Neurol., 34:235-238.
24. Mulholland, G.K, Otto. C.A., Jewett, D.M., Kilbourn, M.R., Koeppe, R.A., Sherman, P.S., Petry, N.A., Carey, J.E., Atkinson, E.R., Archer, S., Frey, K.A., and Kuhl, D.E. (1992) Synthesis, rodent biodistribution, dosimetry, metabolism and monkey images of carbon-11-labeled ( + )-2α-tropanyl benzilate: A central muscarinic receptor imaging agent. J. Nucl. Med., 33:423-430.
25. Namba, H , Irie, T., Fukushi, K., and Iyo, M. (1994) In vivo measurement of acetylcholinesterase activity in the brain with a radioactive acetylcholine analog. Brain Res., 667:278-282.
26. 18F-Labeled vesamicol derivatives: Syntheses and preliminary in vivo small animal positron emission tomography evaluation. Nucl. Med. Biol., 21:219-230.
27. Smolen, A., Smolen, T.N., Wehner, J.M., and Collins, A.C. (1985) Genetically determined differences in acute responses to diisopropylfluorophosphate. Pharmacol. Biochem. Behav., 22:623-630.
28. Smolen, A., Smolen, T.N., Han, P.C., and Collins, A.C. (1987) Sex differences in the recovery of brain acetylcholinesterase activity following a single exposure to DFP. Pharmacol. Biochem. Behav., 26:813-820.
29. Suhara, T., Inoue, O., Kobayashi, K., Suzuki, K., and Tateno, Y. (1993) Age-related changes in human muscarinic acetylcholine receptors measured by positron emission tomography. Neurosci. Lett., 149.225-228.
30. Tavitian, B., Pappata, S., Planas, A.M., Jobert, A., Bonnot-Lours, S., Crouzel, C., and DiGiamberardino, L. (1993) In vivo visualization of acetylcholinesterase with positron emission tomography. Neuro-Report, 4:535-538.
31. Thomsen, T., Kewitz, H., and Pleul, O. (1989) A suitable method to monitor inhibition of cholinesterase activities in tissues as induced by reversible enzyme inhibitors. Enzyme, 42:219-224.
32. 11C]quiniclidinyl benzilate and positron emission tomography in baboons. Eur. J. Pharmacol., 213:275-284.
33. Virgili, M., Contestabile, A., and Barnabei, O. (1991) Postnatal maturation of cholinergic markers in forebrain region of C57BL/6 mice. Dev. Brain Res., 63:281-285.
34. Widen, L., Eriksson, L., Ingvar, M., Parsons, S.M., Rogers, G.A., and Stone-Elander, S. (1993) PET studies of central cholinergic nerve terminals in animals and man. J. Cereb. Blood Flow Metab., 13:S300.
35. 18F]-fluorodexetimide. Life Sci., 48:1385-1394.
36. Wyper, D.J., Brown, D., Patterson, J., Owens, J., Hunter, R., Teasdale, E., and McColluch, J. (1993) Defecits in iodine-labelled 3-quiniclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease. Eur. J. Nucl. Med., 20:379-386.
37. Yoshida, T., Ichiya, Y., Kuwabara, Y., Sasaki, M., Fukumura, T., Ichimya, A., Takita, M., and Masuda, K. (1995) The semiquantiative cerebral cholinergic receptor measurement of patients with Alzheimer's disease and dementia of Alzheimer's type using C-11-NMPB. J. Nucl. Med., 3:238P.
38. Zubieta, J.K., Frey, K.A., Koeppe, R A., Kilbourn, M.R., Mulholland, G.K., Foster, N.L., and Kuhl, D.E. (1994) Muscarinic receptor binding in aging and Alzheimer's disease determined with [C-11] N-methyl-4-piperidyl benzilate and PET. J. Nucl. Med., 35:20P.